Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Allied BiotechROCO:1780 -1.76%77 Days Inventory is 346.24 as of Dec. 2025, which is 13% below its 10-year median of 396.62. GuruFocus rates ROCO:1780 with a GF Score™ of 77/100 and a GF Value™ of NT$20.78 (Fairly Valued). The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Allied Biotech ranks worse than 89.03% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Allied Biotech's Average Total Inventories for the
three
months ended in Dec. 2025 was NT$508.7 Mil. Allied Biotech's Cost of Goods Sold for the
three
months ended in Dec. 2025 was NT$134.1 Mil.
Hence, Allied Biotech's Days Inventory for the
three
months ended in Dec. 2025 was 346.24.
The historical rank and industry rank for Allied Biotech's Days Inventory or its related term are showing as below:
ROCO:1780'
s Days Inventory Range Over the Past 10 Years
Min: 306.78 Med: 396.62 Max: 461.24
Current: 345.39
During the past 13 years, Allied Biotech's highest Days Inventory was 461.24. The lowest was 306.78. And the median was 396.62.
ROCO:1780's Days Inventory is ranked worse than 89.03% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs ROCO:1780: 345.39
Allied Biotech's Days Inventory
declined
from Dec. 2024 (411.00) to Dec. 2025 (346.24).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Allied Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Allied Biotech's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 2.38.
Allied Biotech (ROCO:1780) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Allied Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Allied Biotech's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Allied Biotech Days Inventory Related Terms
Allied Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Allied Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allied Biotech Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Allied Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allied Biotech (ROCO:1780) has a Days Inventory of 346.24 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Allied Biotech and its competitors. This is 13% below median its historical median of 396.62. Over the past decade, Allied Biotech's Days Inventory has ranged from 306.78 to 461.24. According to the industry distribution chart, Allied Biotech ranks #820 out of 921 companies in the Drug Manufacturers industry, placing it in the top 89%.
Is Allied Biotech's Days Inventory too high?
Allied Biotech's current Days Inventory of 346.24 is 13% below median its 10-year median of 396.62. Over the past 10 years, this metric has ranged from a low of 306.78 to a high of 461.24. The Drug Manufacturers industry median Days Inventory is 164.48. Allied Biotech's value of 346.24 is 110.5% above this industry median. Based on the distribution chart, Allied Biotech ranks #820 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Allied Biotech has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Allied Biotech ranks #820 out of 921 companies for Days Inventory. This places Allied Biotech in the lower half of its industry. The industry median Days Inventory is 164.48. Allied Biotech's value of 346.24 is 110.5% above this benchmark. Historically, Allied Biotech's own Days Inventory has ranged from 306.78 to 461.24 over the past decade. While the company's 10-year median is 396.62 vs. the industry median of 164.48, Allied Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allied Biotech's current Days Inventory of 346.24 is 110.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Allied Biotech and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allied Biotech's current Days Inventory is 346.24, which is 13% below median its own 10-year median of 396.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.78, compared to a current price of NT$22.30 — trading 7.3% above its estimated fair value. The current Days Inventory is 346.24, which is 13% below median its 10-year median of 396.62 and 110.5% above the Drug Manufacturers industry median of 164.48. Allied Biotech's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current Days Inventory is 346.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allied Biotech (ROCO:1780) Overvalued in 2026?
Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued.
The current stock price of NT$22.30 is trading 7.3% above its estimated GF Value™ of NT$20.78.
GuruFocus considers Allied Biotech to be Fairly Valued.
Key valuation signals for ROCO:1780:
Days Inventory: 346.24 (13% below median its 10-year median of 396.62)
GF Value™: NT$20.78 vs. price of NT$22.30 (7.3% above fair value)
Industry Position: 110.5% above the Drug Manufacturers median (#820 of 921)
No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
77GF Score
Get the complete analysis for ROCO:1780
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1780 has been successfully added to your 
